Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Oncology Institute (TOI) Long-Term Debt Issuances (2020)

Oncology Institute posted quarterly Long-Term Debt Issuances of $12.3 million for Q4 2020, up 6046.5% on a QoQ basis from $200000.0 in Q1 2020.

Oncology Institute (TOI) has 1 years of Long-Term Debt Issuances data on file, last reported at $12.3 million in Q4 2020.

  • For the quarter ending Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $12.3 million; the trailing twelve-month figure through Sep 2021 stood at $12.3 million (changed N/A YoY), and the FY2022 full-year result was $110.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q4 2020 stood at $12.3 million, up from $200000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $12.3 million in Q4 2020 and bottomed at $200000.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 14.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 1.26 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 250.00 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 582.91 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 135.48 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Oncology Institute 477.45 Mn 447.17 Mn 139.16 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 12.29 Mn
Dec 31, 2020 12.29 Mn
Mar 13, 2020 200,000.00
Mar 13, 2020 200,000.00